ConductScience.org, home

Paper17519898

Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas.

Yu J and 3 others. Br J Cancer, 2007. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas. Papers, record 17519898. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519898

Download JSON
Cell line
ML103 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas.
PubMed
Journal
Br J Cancer
PubMed
Year
2007
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.07
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yu JJ
2Roy DD
3Brockmeyer ADA D
4Dubeau LL

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chromosomal InstabilityMajor topic
CystadenomaMajor topic
DNA, NeoplasmMajor topic
Ovarian NeoplasmsMajor topic
PloidiesMajor topic
Antigens, Polyomavirus Transforming
Cell Line, Tumor
Cells, Cultured
Female
Genetic Vectors
Humans
Telomere

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA079750NCI NIH HHSUnited StatesR01CA079750PubMed and NIHNIH RePORTER
R01 CA119078NCI NIH HHSUnited StatesR01CA119078PubMed and NIHNIH RePORTER
R01CA119078NCI NIH HHSUnited StatesR01CA119078PubMed and NIHNIH RePORTER
R01CA79750NCI NIH HHSUnited StatesR01CA079750PubMed and NIHNIH RePORTER

Download CSV of grants

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112413931Pathology of borderline (low malignant potential) ovarian tumours.Best Pract Res Clin Obstet Gynaecol2002https://conductscience.org/library/papers/12413931PubMed
212204535Telomere dysfunction provokes regional amplification and deletion in cancer genomes.Cancer Cell2002https://conductscience.org/library/papers/12204535PubMed
32172121Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary.Gynecol Oncol1990https://conductscience.org/library/papers/2172121PubMed
48384077Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.Cancer Res1993https://conductscience.org/library/papers/8384077PubMed
56514398Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy.Pathology1984https://conductscience.org/library/papers/6514398PubMed
68606379Potential role of the inactivated X chromosome in ovarian epithelial tumor development.J Natl Cancer Inst1996https://conductscience.org/library/papers/8606379PubMed
78756374The role of DNA flow cytometry in borderline malignant ovarian tumors.Cancer1996https://conductscience.org/library/papers/8756374PubMed
81652450A role for both RB and p53 in the regulation of human cellular senescence.Exp Cell Res1991https://conductscience.org/library/papers/1652450PubMed
98364906Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas.Cancer Res1993https://conductscience.org/library/papers/8364906PubMed
1016243797Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges.Clin Cancer Res2005https://conductscience.org/library/papers/16243797PubMed
1110029684Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential.Mutat Res1999https://conductscience.org/library/papers/10029684PubMed
129091645Telomerase activity in benign and malignant epithelial ovarian tumors.J Natl Cancer Inst1997https://conductscience.org/library/papers/9091645PubMed
139020485Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis.Br J Cancer1997https://conductscience.org/library/papers/9020485PubMed
148463035The behavior of serous tumors of low malignant potential: are they ever malignant?Int J Gynecol Pathol1993https://conductscience.org/library/papers/8463035PubMed
1515077125Molecular genetic analysis of ovarian serous cystadenomas.Lab Invest2004https://conductscience.org/library/papers/15077125PubMed
169441775Establishment of long-term in vitro cultures of human ovarian cystadenomas and LMP tumors and examination of their spectrum of expression of matrix-degrading proteinases.Gynecol Oncol1997https://conductscience.org/library/papers/9441775PubMed
1715466181Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors.Cancer Res2004https://conductscience.org/library/papers/15466181PubMed
1811240673The management of borderline epithelial tumors of the ovary.Int J Gynecol Cancer2000https://conductscience.org/library/papers/11240673PubMed
191582420Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.EMBO J1992https://conductscience.org/library/papers/1582420PubMed
2010949306Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.Nature2000https://conductscience.org/library/papers/10949306PubMed

See all 26 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
26568913Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications.Transl Cancer Res2015https://conductscience.org/library/papers/26568913PubMed
24131966Coming into focus: the nonovarian origins of ovarian cancer.Ann Oncol2013https://conductscience.org/library/papers/24131966PubMed
23415752BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.Mol Oncol2013https://conductscience.org/library/papers/23415752PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
H3P16644914PubTator's text mininghttps://conductscience.org/library/genes/644914NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17519898

GET https://conductscience.org/api/papers/v1/17519898/references?page=2